![]() |
Name |
N-(4,6-Dimethyl-2-pyrimidinyl)-4-(4-nitrobenzylideneamino)benzenesulfonamide
|
Molecular Formula | C19H17N5O4S | |
IUPAC Name* |
N-(4,6-dimethylpyrimidin-2-yl)-4-[(4-nitrophenyl)methylideneamino]benzenesulfonamide
|
|
SMILES |
CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N=CC3=CC=C(C=C3)[N+](=O)[O-])C
|
|
InChI |
InChI=1S/C19H17N5O4S/c1-13-11-14(2)22-19(21-13)23-29(27,28)18-9-5-16(6-10-18)20-12-15-3-7-17(8-4-15)24(25)26/h3-12H,1-2H3,(H,21,22,23)
|
|
InChIKey |
PYJURCWCTIZJHX-UHFFFAOYSA-N
|
|
Synonyms |
Oprea1_431682; ZINC1052525; STK662332; AKOS005525851; N-(4,6-Dimethyl-2-pyrimidinyl)-4-(4-nitrobenzylideneamino)benzenesulfonamide; N-(4,6-dimethylpyrimidin-2-yl)-4-{[(E)-(4-nitrophenyl)methylidene]amino}benzenesulfonamide; N-(4,6-Dimethyl-2-pyrimidinyl)-4-([(E)-(4-nitrophenyl)methylidene]amino)benzenesulfonamide #; N~1~-(4,6-dimethyl-2-pyrimidinyl)-4-{[(E)-1-(4-nitrophenyl)methylidene]amino}-1-benzenesulfonamide
|
|
CAS | NA | |
PubChem CID | 542809 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 411.4 | ALogp: | 2.1 |
HBD: | 1 | HBA: | 8 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 139.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 29 | QED Weighted: | 0.366 |
Caco-2 Permeability: | -4.994 | MDCK Permeability: | 0.00002240 |
Pgp-inhibitor: | 0.016 | Pgp-substrate: | 0.013 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0 |
Blood-Brain-Barrier Penetration (BBB): | 0.382 | Plasma Protein Binding (PPB): | 99.14% |
Volume Distribution (VD): | 0.342 | Fu: | 1.07% |
CYP1A2-inhibitor: | 0.489 | CYP1A2-substrate: | 0.655 |
CYP2C19-inhibitor: | 0.441 | CYP2C19-substrate: | 0.066 |
CYP2C9-inhibitor: | 0.661 | CYP2C9-substrate: | 0.076 |
CYP2D6-inhibitor: | 0.207 | CYP2D6-substrate: | 0.088 |
CYP3A4-inhibitor: | 0.65 | CYP3A4-substrate: | 0.827 |
Clearance (CL): | 1.185 | Half-life (T1/2): | 0.134 |
hERG Blockers: | 0.721 | Human Hepatotoxicity (H-HT): | 0.951 |
Drug-inuced Liver Injury (DILI): | 0.989 | AMES Toxicity: | 0.973 |
Rat Oral Acute Toxicity: | 0.58 | Maximum Recommended Daily Dose: | 0.314 |
Skin Sensitization: | 0.262 | Carcinogencity: | 0.924 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.056 |
Respiratory Toxicity: | 0.804 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000113 | ![]() |
0.529 | D0V9YR | ![]() |
0.529 | ||
ENC000112 | ![]() |
0.394 | D0H1GJ | ![]() |
0.394 | ||
ENC000109 | ![]() |
0.316 | D02ZTJ | ![]() |
0.356 | ||
ENC000114 | ![]() |
0.314 | D09MGR | ![]() |
0.333 | ||
ENC000034 | ![]() |
0.306 | D05LKP | ![]() |
0.316 | ||
ENC002379 | ![]() |
0.278 | D05UWI | ![]() |
0.316 | ||
ENC004461 | ![]() |
0.278 | D07SYJ | ![]() |
0.314 | ||
ENC001364 | ![]() |
0.271 | D09TBD | ![]() |
0.313 | ||
ENC001517 | ![]() |
0.255 | D0A4YE | ![]() |
0.309 | ||
ENC001406 | ![]() |
0.252 | D0T1GT | ![]() |
0.308 |